OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM)
Titel:
OAB-026: MagnetisMM-1 study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA) targeted CD3-engaging bispecific molecule, for patients (pts) with relapsed or refractory multiple myeloma (MM)
Auteur:
Dholaria, Bhagirathbhai Bahlis, Nizar Raje, Noopur Costello, Caitlin Solh, Melhem Levy, Moshe Tomasson, Michael Dube, Harman Damore, Michael Lon, Hoi Kei Basu, Cynthia Skoura, Athanasia Chan, Edward Trudel, Suzanne Jakubowiak, Andrzej Chu, Michael Gasparetto, Cristina Dalovisio, Andrew Sebag, Michael Lesokhin, Alexander